OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Abemaciclib induces atypical cell death in cancer cells characterized by formation of cytoplasmic vacuoles derived from lysosomes
Hirotsugu Hino, Noriyoshi Iriyama, Hiroko Kokuba, et al.
Cancer Science (2020) Vol. 111, Iss. 6, pp. 2132-2145
Open Access | Times Cited: 63
Hirotsugu Hino, Noriyoshi Iriyama, Hiroko Kokuba, et al.
Cancer Science (2020) Vol. 111, Iss. 6, pp. 2132-2145
Open Access | Times Cited: 63
Showing 1-25 of 63 citing articles:
The V-ATPases in cancer and cell death
Fangquan Chen, Rui Kang, Jiao Liu, et al.
Cancer Gene Therapy (2022) Vol. 29, Iss. 11, pp. 1529-1541
Open Access | Times Cited: 76
Fangquan Chen, Rui Kang, Jiao Liu, et al.
Cancer Gene Therapy (2022) Vol. 29, Iss. 11, pp. 1529-1541
Open Access | Times Cited: 76
Targeting Autophagy in Breast Cancer
Stefania Cocco, Alessandra Leone, Michela Piezzo, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 21, pp. 7836-7836
Open Access | Times Cited: 78
Stefania Cocco, Alessandra Leone, Michela Piezzo, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 21, pp. 7836-7836
Open Access | Times Cited: 78
Dissolution of oncofusion transcription factor condensates for cancer therapy
Y Wang, Chunyu Yu, Gaofeng Pei, et al.
Nature Chemical Biology (2023) Vol. 19, Iss. 10, pp. 1223-1234
Closed Access | Times Cited: 32
Y Wang, Chunyu Yu, Gaofeng Pei, et al.
Nature Chemical Biology (2023) Vol. 19, Iss. 10, pp. 1223-1234
Closed Access | Times Cited: 32
CDK4/6 inhibitors in lung cancer: current practice and future directions
Shuoshuo Lv, Jie Yang, Jiayuh Lin, et al.
European Respiratory Review (2024) Vol. 33, Iss. 171, pp. 230145-230145
Open Access | Times Cited: 10
Shuoshuo Lv, Jie Yang, Jiayuh Lin, et al.
European Respiratory Review (2024) Vol. 33, Iss. 171, pp. 230145-230145
Open Access | Times Cited: 10
Pharmacological CDK4/6 inhibition promotes vulnerability to lysosomotropic agents in breast cancer
Jamil Nehme, Sjors Maassen, Sara Bravaccini, et al.
The EMBO Journal (2025)
Open Access | Times Cited: 1
Jamil Nehme, Sjors Maassen, Sara Bravaccini, et al.
The EMBO Journal (2025)
Open Access | Times Cited: 1
Effect of palliative radiotherapy and cyclin-dependent kinase 4/6 inhibitor on breast cancer cell lines
Marwa Sharaky, Shereen M. El kiki, Heba Effat, et al.
Naunyn-Schmiedeberg s Archives of Pharmacology (2025)
Open Access | Times Cited: 1
Marwa Sharaky, Shereen M. El kiki, Heba Effat, et al.
Naunyn-Schmiedeberg s Archives of Pharmacology (2025)
Open Access | Times Cited: 1
Natural product manoalide promotes EGFR-TKI sensitivity of lung cancer cells by KRAS-ERK pathway and mitochondrial Ca2+ overload-induced ferroptosis
Yinyun Ni, Jiaye Liu, Lingyan Zeng, et al.
Frontiers in Pharmacology (2023) Vol. 13
Open Access | Times Cited: 18
Yinyun Ni, Jiaye Liu, Lingyan Zeng, et al.
Frontiers in Pharmacology (2023) Vol. 13
Open Access | Times Cited: 18
Modulation of autophagy and apoptosis can contribute to the anticancer effect of Abemaciclib/Celecoxib combination in colon cancer cells
Dalia Mohamed Elsayed Alian, Maged W. Helmy, Medhat Haroun, et al.
Medical Oncology (2024) Vol. 41, Iss. 2
Open Access | Times Cited: 8
Dalia Mohamed Elsayed Alian, Maged W. Helmy, Medhat Haroun, et al.
Medical Oncology (2024) Vol. 41, Iss. 2
Open Access | Times Cited: 8
Immunomodulatory effects of CDK4/6 inhibitors
Shumeng Zhang, Qiaomai Xu, Wenjia Sun, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2023) Vol. 1878, Iss. 4, pp. 188912-188912
Closed Access | Times Cited: 16
Shumeng Zhang, Qiaomai Xu, Wenjia Sun, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2023) Vol. 1878, Iss. 4, pp. 188912-188912
Closed Access | Times Cited: 16
PI5P4Kα supports prostate cancer metabolism and exposes a survival vulnerability during androgen receptor inhibition
Joanna Triscott, Matthias Reist, L KUNG, et al.
Science Advances (2023) Vol. 9, Iss. 5
Open Access | Times Cited: 14
Joanna Triscott, Matthias Reist, L KUNG, et al.
Science Advances (2023) Vol. 9, Iss. 5
Open Access | Times Cited: 14
Targeting VPS41 induces methuosis and inhibits autophagy in cancer cells
Yue Liu, Yong Sun, Yuliang Xu, et al.
Cell chemical biology (2023) Vol. 30, Iss. 2, pp. 130-143.e5
Open Access | Times Cited: 13
Yue Liu, Yong Sun, Yuliang Xu, et al.
Cell chemical biology (2023) Vol. 30, Iss. 2, pp. 130-143.e5
Open Access | Times Cited: 13
The Role of CD4/6 Inhibitors in Breast Cancer Treatment
Luv Purohit, Can Jones, Teresita Gonzalez, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 2, pp. 1242-1242
Open Access | Times Cited: 5
Luv Purohit, Can Jones, Teresita Gonzalez, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 2, pp. 1242-1242
Open Access | Times Cited: 5
Cyclin-dependent kinase inhibitors in head and neck cancer and glioblastoma—backbone or add-on in immune-oncology?
Christin Riess, Nina Irmscher, Inken Salewski, et al.
Cancer and Metastasis Reviews (2020) Vol. 40, Iss. 1, pp. 153-171
Open Access | Times Cited: 35
Christin Riess, Nina Irmscher, Inken Salewski, et al.
Cancer and Metastasis Reviews (2020) Vol. 40, Iss. 1, pp. 153-171
Open Access | Times Cited: 35
Cyclin-dependent kinase inhibitors exert distinct effects on patient-derived 2D and 3D glioblastoma cell culture models
Christin Riess, Dirk Koczan, Björn Schneider, et al.
Cell Death Discovery (2021) Vol. 7, Iss. 1
Open Access | Times Cited: 29
Christin Riess, Dirk Koczan, Björn Schneider, et al.
Cell Death Discovery (2021) Vol. 7, Iss. 1
Open Access | Times Cited: 29
Estrogen receptor β activation inhibits colitis by promoting NLRP6-mediated autophagy
Wentao Fan, Chenchen Ding, Shuhui Liu, et al.
Cell Reports (2022) Vol. 41, Iss. 2, pp. 111454-111454
Open Access | Times Cited: 22
Wentao Fan, Chenchen Ding, Shuhui Liu, et al.
Cell Reports (2022) Vol. 41, Iss. 2, pp. 111454-111454
Open Access | Times Cited: 22
Multi salt strategy based on curcumin pyrimidine derivatives prodrugs: Synthesis, biological activity, in vitro and in vivo imaging, and drug distribution research
Guangchang Lian, Ying Liu, Kaibo Hu, et al.
Dyes and Pigments (2023) Vol. 216, pp. 111310-111310
Closed Access | Times Cited: 11
Guangchang Lian, Ying Liu, Kaibo Hu, et al.
Dyes and Pigments (2023) Vol. 216, pp. 111310-111310
Closed Access | Times Cited: 11
Methuosis Inducer SGI‐1027 Cooperates with Everolimus to Promote Apoptosis and Pyroptosis by Triggering Lysosomal Membrane Permeability in Renal Cancer
Yu Luo, Bing Guan, Xiaoqi Deng, et al.
Advanced Science (2024) Vol. 11, Iss. 38
Open Access | Times Cited: 4
Yu Luo, Bing Guan, Xiaoqi Deng, et al.
Advanced Science (2024) Vol. 11, Iss. 38
Open Access | Times Cited: 4
Prosapogenin A induces GSDME-dependent pyroptosis of anaplastic thyroid cancer through vacuolar ATPase activation-mediated lysosomal over-acidification
Yunye Liu, Yawen Guo, Qian Zeng, et al.
Cell Death and Disease (2024) Vol. 15, Iss. 8
Open Access | Times Cited: 4
Yunye Liu, Yawen Guo, Qian Zeng, et al.
Cell Death and Disease (2024) Vol. 15, Iss. 8
Open Access | Times Cited: 4
Kinase Inhibitor-Induced Cell-Type Specific Vacuole Formation in the Absence of Canonical ATG5-Dependent Autophagy Initiation Pathway
Susan Jose, Himanshi Sharma, Janki Insan, et al.
Molecular and Cellular Biology (2025), pp. 1-17
Closed Access
Susan Jose, Himanshi Sharma, Janki Insan, et al.
Molecular and Cellular Biology (2025), pp. 1-17
Closed Access
Poly(amino acid) nanoformulation of cyclin-dependent kinase 4 and 6 inhibitor for molecularly targeted immunotherapy in triple-negative breast cancer
Xue Wei, Ming Yang, Haoyang Zou, et al.
Journal of Controlled Release (2025) Vol. 380, pp. 760-772
Closed Access
Xue Wei, Ming Yang, Haoyang Zou, et al.
Journal of Controlled Release (2025) Vol. 380, pp. 760-772
Closed Access
Cytoplasmic Vacuolization: A Fascinating Morphological Alteration From Cellular Stress to Cell Death
Xiaoxu Wen, Hongru Ma
Cancer Science (2025)
Open Access
Xiaoxu Wen, Hongru Ma
Cancer Science (2025)
Open Access
Increased Mitochondrial Superoxide Level Is Partially Associated With Vemurafenib‐Induced Renal Tubular Toxicity
Akimasa Sanagawa, Hiroshi Takase
Basic & Clinical Pharmacology & Toxicology (2025) Vol. 136, Iss. 4
Open Access
Akimasa Sanagawa, Hiroshi Takase
Basic & Clinical Pharmacology & Toxicology (2025) Vol. 136, Iss. 4
Open Access
How selective are clinical CDK4/6 inhibitors?
Denisa Hendrychová, Radek Jorda, Vladimı́r Kryštof
Medicinal Research Reviews (2020) Vol. 41, Iss. 3, pp. 1578-1598
Closed Access | Times Cited: 25
Denisa Hendrychová, Radek Jorda, Vladimı́r Kryštof
Medicinal Research Reviews (2020) Vol. 41, Iss. 3, pp. 1578-1598
Closed Access | Times Cited: 25
Implementation of a combined CDK inhibition and arginine-deprivation approach to target arginine-auxotrophic glioblastoma multiforme cells
Christin Riess, Katharina del Moral, Adina Fiebig, et al.
Cell Death and Disease (2022) Vol. 13, Iss. 6
Open Access | Times Cited: 16
Christin Riess, Katharina del Moral, Adina Fiebig, et al.
Cell Death and Disease (2022) Vol. 13, Iss. 6
Open Access | Times Cited: 16
